[The progress and prospect of ophthalmological research on cerebral visual impairment in children]

C Zhang1, X Q Zhao2, H J Sun1

  • 1Department of Ophthalmology, The Second Affiliated Hospital of Army Medical University, Chongqing 400037, China.

Insights

Cerebral visual impairment (CVI) is rising in children due to improved neonatal survival. Early ophthalmology diagnosis and intervention are crucial for improving CVI children's quality of life.

Area of Science:

  • Ophthalmology
  • Neonatal Medicine
  • Pediatrics

Background:

  • Improved survival rates for high-risk neonates have led to an increased incidence of cerebral visual impairment (CVI).
  • CVI is a leading cause of childhood visual impairment in developed nations, presenting with diverse visual abnormalities.
  • Children with CVI often exhibit sensory, cognitive, and motor deficits beyond visual impairment.

Purpose of the Study:

  • To review recent advancements in ophthalmology diagnosis and treatment for pediatric CVI.
  • To emphasize the importance of early recognition and individualized intervention strategies.
  • To support pediatricians and rehabilitation physicians in enhancing the quality of life for children with CVI.

Main Methods:

  • Literature review focusing on ophthalmology perspectives.
  • Analysis of recent progress in CVI diagnosis and treatment.
  • Synthesis of information relevant to multidisciplinary care.

Main Results:

  • CVI presents complex challenges including early onset, varied etiology, and diagnostic difficulties.
  • Multidisciplinary approaches involving ophthalmology, pediatrics, and rehabilitation are essential.
  • Current domestic research on CVI remains limited.

Conclusions:

  • Enhanced ophthalmological understanding is vital for effective CVI management.
  • Early and individualized interventions can significantly improve outcomes for children with CVI.
  • Collaboration among specialists is key to improving survival skills and quality of life.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
434
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
265
Cerebral Hemispheres01:05

Cerebral Hemispheres

The human brain, a complex organ, is functionally divided into two cerebral hemispheres—left and right. These hemispheres are interconnected by a structure of paramount importance, the corpus callosum. This substantial bundle of neural fibers is not just a bridge between the hemispheres but a crucial element for the brain's comprehensive functioning. It enables efficient communication between the two hemispheres, allowing each side of the brain to control and receive sensory and motor...
2.2K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
261